How does health advocacy in the workplace build better business outcomes? 🤔 Creating a culture where employees feel empowered to take charge of their health can lead to healthier choices, better productivity, and significant cost savings. Rachel Feferman explains more in our latest article: 👉 https://lnkd.in/eYpuA7GS #EmployeeWellbeing #HealthAdvocacy #HRInsights #Noom
Noom
Wellness and Fitness Services
New York, NY 105,008 followers
Helping people everywhere lead happier, healthier lives through behavior change.
About us
Noom is the world's leading behavior change company, disrupting the weight loss and healthcare industries. By combining the power of artificial intelligence, mobile tech, and psychology with the empathy of personal coaches, Noom helps people live healthier lives by changing their long-term habits. More than 50 million people have benefited from Noom’s behavior change courses, including its virtual diabetes prevention program, which was the first of its kind to be recognized by the CDC. The Noom platform is already being used by leading healthcare and pharmaceutical companies to improve treatment outcomes for patients worldwide. The company is headquartered in New York City with employees living and working worldwide. To learn more about careers with Noom, visit https://www.noom.com/careers **Disclaimer: Noom, Inc. job offers will only come from @noom.com personnel. Do not believe fraudulent Recruiters or similar domain names. @noomteam.com and similar [noomjobname]@gmail are not affiliated whatsoever with Noom, Inc.**
- Website
-
http://www.noom.com/
External link for Noom
- Industry
- Wellness and Fitness Services
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Specialties
- Technology, Wellness, Weight-Loss, iOS, Android, Mobile, Startup, Diet, Health, Fitness, Lifestyle, Behavior Change, and Psychology
Locations
-
Primary
Get directions
New York, NY 10001, US
Employees at Noom
Updates
-
Our Co-Founder and Executive Chairman, Saeju Jeong, recently joined the Just FlexIt™ podcast (via FlexIt Inc.) to share his journey founding Noom and how our approach to transforming health and wellness has evolved over time. From his passion for heavy metal to his vision for the future, Saeju dives deep into what drives him both personally and professionally. 🎙️ Tune in to hear more about Noom’s path and what’s next! bit.ly/3zyUYFz
-
-
Noom was featured in The Hill, where our CEO, Geoff Cook, shared insights on the affordability of GLP-1 medications. As Geoff noted, "It’s really only in the U.S. that pricing is five times that on the brand name drug." With Noom GLP-1ᴿˣ, our compounded GLP-1 medications paired with our behavior change program, we’re helping to close this gap while empowering people to build healthier habits and transform their lives. Read the full story: bit.ly/4egP4YH
-
🤝 Noom has partnered with Mount Sinai Health System to provide patients with a whole-person approach to healthy, sustainable weight loss. Through this partnership, Mount Sinai physicians can refer patients to Noom's digital behavior-change platform. Patients prescribed certain medications can also access tailored support through the Noom GLP-1 Companion program. Learn more about how we're transforming healthcare together: https://lnkd.in/eKUzdD9k
Mount Sinai Health System and Noom Partner to Help Patients Achieve Healthy Weight Loss Outcomes With an On-Demand Digital Health Platform
mountsinai.org
-
Today, as part of a Senate hearing examining the high cost of obesity medications, we’re submitting an official statement to the congressional record urging lawmakers to ensure affordable and fair pricing for GLP-1 meds for all Americans. In tandem, our latest Wall Street Journal ad highlights the pressing need for equitable access to these life-changing treatments. Join us in advocating for sustainable solutions by signing our petition. ✍️ https://lnkd.in/e_B_ZvJi
No one should have to pay 10x more for the same weight-loss medications ... That's why we submitted an official statement to the congressional record at this morning’s Senate hearing with three specific recommendations to help end the obesity epidemic. That's why we launched a petition requesting policymakers not to allow the only affordable GLP-1s to be forced off the market without fair brand-name pricing. And that's why we ran a full-page ad on the back cover of today's Wall Street Journal encouraging the Senate Committee to focus on two key questions. The removal of Wegovy and Zepbound from the FDA drug shortage list will also remove the only affordable GLP-1 medications from the US market, forcing large numbers of citizens to discontinue vital treatments or else face a large price hike. Noom calls for caution to avoid such harm. Our proposal is as simple as it is modest ... We ask pharmaceutical companies for data to show how they will meet the demand of these potentially millions of citizens, allow a lengthy grace period so that folks do not lose access to their obesity and diabetes medications overnight, and base the length of the grace period on achieving fair US pricing—as measured by the global price of the SAME medications. For the last year, our program prescribed only brand-name meds. We've seen firsthand how many folks can't access the medications because of the high U.S. pricing. These high prices discourage health plans from covering the med, restricting access. We've seen even those fortunate enough to have good insurance to also not be able to access the medication because of the short supply. We prescribe brand-name meds to patients who can access them and affordably-priced medications produced via 503B FDA-regulated outsourcing facilities to those who cannot. We ask for affordable choices and fair pricing for obesity and diabetes medications.
-
-
Please join us in welcoming Rachel Mahoney, Noom’s new Chief Brand Officer! 🤝 Her incredible work with major brands will help Noom continue to deliver sustainable weight loss approaches to people everywhere, including through our newly launched GLP-1ᴿˣ solution.
Noom Appoints Rachel Mahoney as Chief Brand Officer
globenewswire.com
-
As the demand for weight loss solutions continues to grow, affordability and access remain key challenges. In response, we've launched Noom GLP-1ᴿˣ, offering compounded semaglutide at one of the most competitive prices in the industry. Paired with our behavior change platform, we're empowering individuals to achieve sustainable, long-term weight loss. Read more on how Noom is leading the charge in making healthcare more accessible in Quartz.
Another digital healthcare company is selling off-brand weight loss drugs — for pretty cheap
qz.com
-
By combining the power of compounded GLP-1 medications with Noom’s behavior change program, we’re offering a holistic approach to weight management. 🎙️ In this CNBC article, Noom CEO Geoff Cook and Chief Medical Officer Dr. Adonis Saremi, MD, MS, discuss how Noom is shaping the future of accessible, medically-guided weight loss.
Digital health company Noom is offering compounded GLP-1 drugs to patients in new weight loss program
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
cnbc.com
-
Exciting times at Noom! 🚀 Check out how we're making GLP-1s more accessible, paired with our proven behavior change program. Catch CEO Geoff Cook's deep dive into Noom GLP-1ᴿˣ on #NYSEFloorTalk with Judy Khan Shaw (via NYSE).
News from Noom! Noom has announced they’re providing GLP-1s to kickstart your weight loss journey with affordable pricing. They’re pairing it with the psychology-based program needed to sustain the weight loss, and the ability to one day live med-free. CEO Geoff Cook joins Judy Khan Shaw on #NYSEFloorTalk to talk about their new product, Noom GLP-1ᴿˣ. Press release: http://spr.ly/6044Wt1lu
-
ANNOUNCEMENT 📣 Introducing Noom GLP-1ᴿˣ - compounded semaglutide starting at just $149, making the weight loss journey more affordable, accessible, and sustainable. This physician and psychology-backed program is designed to not only help users achieve their goals, but also taper off the meds over time. Get full access to the Noom app, including GLP-1 Companion now with Muscle Defense™ - featuring a protein tracker, strength workouts, and more to combat muscle loss. Learn more about Noom GLP-1Rx: https://lnkd.in/gSu43ysa
-